Higher levels of matrix metalloproteinase-3 in patients with RA reflect disease activity and structural damage

Martina Skacelova1, Zuzana Hermanova2, Pavel Horak1

  • 1Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic.

Abstract

Insights

Matrix metalloproteinase-3 (MMP-3) serum levels are significantly elevated in rheumatoid arthritis (RA) patients, indicating its potential as a marker for disease activity and joint damage.

Area of Science:

  • Rheumatology
  • Biochemistry
  • Immunology

Background:

  • Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation and damage.
  • Identifying reliable biomarkers for disease activity and progression is crucial for effective RA management.
  • Matrix metalloproteinase-3 (MMP-3) is an enzyme involved in extracellular matrix degradation, implicated in joint pathology.

Purpose of the Study:

  • To investigate serum MMP-3 levels as a potential biomarker for disease activity and joint damage in RA.
  • To compare MMP-3 concentrations in RA patients with those in osteoarthritis (OA) patients and healthy controls.
  • To correlate MMP-3 levels with established clinical and laboratory markers of RA disease status.

Main Methods:

  • Serum samples were collected from 92 RA patients, 24 OA patients, and 26 healthy controls.
  • MMP-3 concentrations were quantified using ELISA (AESKU.Diagnostics).
  • MMP-3 levels were compared with clinical scores (DAS28), radiographic staging, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and anti-cyclic citrullinated peptide (anti-CCP) antibodies.

Main Results:

  • Mean serum MMP-3 levels were significantly higher in RA patients (199.1 ng/mL) compared to OA patients (113.9 ng/mL) and healthy controls (48.3 ng/mL) (P<0.0001).
  • Significant correlations were observed between MMP-3 levels and CRP (r=0.304), DAS28 (r=0.301), anti-CCP antibodies (r=0.241), ESR (r=0.200), and radiographic disease stage (r=0.197).
  • These findings highlight MMP-3's association with various indicators of RA disease activity and structural damage.

Conclusions:

  • Serum MMP-3 measurement shows promise as a valuable biomarker for assessing disease activity in rheumatoid arthritis.
  • Elevated MMP-3 levels reflect active joint inflammation and potential for joint damage in RA patients.
  • MMP-3 could serve as an adjunct marker to complement existing methods for RA monitoring.

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
3.5K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.9K
Extracellular Matrix01:26

Extracellular Matrix

Unlike epithelial tissue, which is composed of cells closely packed with little or no extracellular space in between, connective tissue cells are dispersed in a matrix. This extracellular matrix (ECM) is composed of fibrous proteins like collagen, elastin, and fibronectin in a ground substance consisting of interstitial fluid, cell adhesion proteins, and proteoglycans. The proteoglycans form a gel-like material in the spaces between cells and provide hydration, buffering, binding, and force...
6.1K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
793
The Extracellular Matrix01:29

The Extracellular Matrix

Overview
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
12.8K